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Patients at elevated cardiovascular risk are prone to perioperative cardiovascular
complications, like myocardial injury after non-cardiac surgery (MINS). We have
demonstrated in a mouse model of atherosclerosis that perioperative stress leads to
an increase in plaque volume and higher plaque vulnerability. Regulatory T cells (Tregs)
play a pivotal role in development and destabilization of atherosclerotic plaques. For
this exploratory post-hoc analysis we identified 40 patients recruited into a prospective
perioperative biomarker study, who within the inclusion period underwent sequential
open vascular surgery. On the basis of protein markers measured in the biomarker
study, we evaluated the perioperative inflammatory response in patients’ plasma before
and after index surgery as well as before and after a second surgical procedure. We
also analyzed available immunohistochemistry samples to describe plaque vulnerability
in patients who underwent bilateral carotid endarterectomy (CEA) in two subsequent
surgical procedures. Finally, we assessed if MINSwas associated with sequential surgery.
The inflammatory response of both surgeries was characterized by postoperative
increases of interleukin-6,−10, Pentraxin 3 and C-reactive protein with no clear-cut
difference between the two time points of surgery. Plaques from CEA extracted
during the second surgery contained less Tregs, as measured by Foxp3 staining,
than plaques from the first intervention. The 2nd surgical procedure was associated
with MINS. In conclusion, we provide descriptive evidence that sequential surgical
procedures involve repeat inflammation, and we hypothesize that elevated rates of
cardiovascular complications after the second procedure could be related to reduced
levels of intraplaque Tregs, a finding that deserves confirmatory testing and mechanistic
exploration in future populations.
Keywords: perioperative inflammation, regulatory T cells, plaque vulnerability, cardiac adverse event, vascular
surgery, interleukin-6
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INTRODUCTION
Patients at elevated risk for cardiovascular complications
are prone to perioperative adverse cardiac events, such as
myocardial injury after non-cardiac surgery (MINS) (1) and face
higher perioperative mortality (1–4). Atherosclerosis and its
complications are driven by systemic inflammation (5), however
the mechanisms underlying perioperative cardiovascular
complications are not fully understood (6, 7). We and others
have demonstrated that in mouse models of atherosclerosis,
perioperative stress leads to a systemic inflammatory reaction
resulting in a rapid, interleukin-6 (IL-6)-dependent, expansion
of plaque volume and increase in plaque vulnerability (8, 9).
Perioperatively released IL-6 might also have an important role
in human plaque fissuring (10). In mice and man, unstable
atherosclerotic lesions are prone to the development of plaque
fissures and rupture (11, 12). Plaque fissures and ruptures are
among the mechanisms underlying MINS (7). About 25% of
patients with perioperative acute coronary synrome show signs
of coronary plaque rupture (13).
Low numbers of regulatory T cells (Tregs) in blood, as well
as in human atherosclerotic plaque, are associated with plaque
vulnerability (14, 15) and modulating Treg numbers in mouse
models of atherosclerosis regulates progression of atherosclerotic
lesion development (16). Additionally, we have recently shown
that preoperative low counts of Tregs are associated with higher
rates of MINS and adverse cardiovascular outcome in patients
with coronary heart disease undergoing non-cardiac surgery (17).
However, it is unknown if perioperative stress associated with
surgical procedures renders patients prone to MINS. Also, it is
unclear whether Treg numbers in atherosclerotic lesions as a
measure of plaque stability are affected by surgical interventions.
Therefore, for this explorative post-hoc analysis we identified
all patients from a perioperative vascular surgery biomarker
study (18, 19), who within the study recruitment period
underwent sequential vascular surgical procedures such as
carotid endarterectomy (CEA). We described the systemic
perioperative inflammatory response and quantified Tregs as a
measure of plaque stability in available CEA samples from the
first (1st) and second (2nd) intervention and compared MINS
rates between the two sequential surgeries. We demonstrate that
surgery is associated with cardiac complications in subsequent
surgical procedures, and we provide descriptive evidence for the
hypothesis that enhanced plaque vulnerability might be related
to MINS.
MATERIALS AND METHODS
Study Design and Selected Population
Details concerning study design and enrollment are reported
in Gillmann et al. (18) and Schrimpf et al. (19). In brief,
within a single-center, prospective, observational study aiming at
identification of patients at risk for perioperative cardiovascular
complications, 644 consecutive patients undergoing an elective
open vascular procedure (aortic, peripheral artery or carotid
surgery) in general anesthesia were prospectively recruited into
a biomarker study. Endovascular procedures were not included.
The study was performed between June 2007 and October 2012
at the Department of Cardiac, Thoracic, Transplantation and
Vascular Surgery and the Department of Anesthesiology and
Intensive Care Medicine at Hannover Medical School and was
approved by the Hannover Medical School’s Ethics Committee
(approval no. 4598, 14/MAY/2007). Written informed consent
was obtained from all patients prior to enrollment into the
biomarker study. Patients were followed up for the occurrence
of major cardiovascular events until the 30th postsurgical day,
pre- and postoperative day-1 plasma samples as well as available
endarterectomy samples were collected as published before (18,
19). In this exploratory post-hoc analysis, we included all 40
patients who underwent two sequential surgical procedures
within the recruitment period. Patient flow and availability of
patients’ plasma and CEA samples are depicted in Figure 1.
After the 1st surgery, two postoperative plasma samples and
after the 2nd surgery one postoperative plasma sample were
lost because of technical difficulties. For histology analyses,
we identified 21 patients who underwent bilateral CEA in the
inclusion period. These patients were screened for histological
analysis for direct comparison for each patient between the
sequential procedures. Damaged samples were excluded, leaving
17 patients being selected for histological assessment with two
samples per patient (Figure 1).
MINS was defined as any increase in postoperative high-
sensitive cardiac troponin T (hs-cTnT) ≥50 ng l−1 (20) judged
due to myocardial ischemia. Hs-cTnT rise was defined as an
increase of at least 50% from baseline (21). Troponin elevations
were judged to be due to myocardial injury if no evidence
for primarily extracardiac diseases such as sepsis or pulmonary
embolism was observed.
Biochemical Analysis in Plasma
Blood samples for biomarker measurements were collected
immediately before surgery and on day one after surgery.
Plasma was stored at −80◦C and measurements were performed
in batch assays. Hs-cTnT levels were measured preoperatively
and postoperatively (Hs-cTnT; Roche Diagnostics, Mannheim,
Germany; Elecsys R© 2010/ cobasTM e411 immunoanalyser).
A commercially available enzyme-linked immunosorbent assay
(ELISA) was used to measure plasma levels of Pentraxin 3
(PTX3) (R&D Systems, Minneapolis, USA). Plasma levels of IL-6
and Interleukin-10 (IL-10) were measured by a cytometric bead
array (CBA) (BD Biosciences, Franklin Lakes, USA). C-reactive
protein (CRP) measurements were pulled from patients’ regular
perioperative blood work which were performed in the hospital’s
laboratory for routine measurements.
Histological Analysis on Carotid Artery
Plaque
From patients who underwent procedures with endarterectomy,
samples were collected and cryoembedded in Tissue Tek O.C.T..
Serial cryosections from available CEA were cut at a thickness
of 5µm. Series of 25 serial slides were prepared. The first
25 cryosections were each placed on position one of the 25
slides. The next 25 sections were placed on position two and
the third 25 slides were placed on position three. Thus, on
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FIGURE 1 | Patient flow chart. CEA, Carotid endarterectomy.
each cryosection the distance from slice one to two and from
two to three was 125µm. In total, each microscopic slide
represented a distance of 250µm. Sections were stained for
Hematoxylin & Eosin (H&E) and then subjected to further
immunohistochemical analyses. For each sample we identified
the most advanced part of the plaque, which was used for
immunohistochemical analyses. For each staining, 3 slides
(in total 9 sections) were analyzed (Supplementary Figure 1).
Double fluorescent immune histochemical stainings were
performed for macrophages (mouse anti-human CD68, clone
KP1, DAKO, Santa Clara, USA) and collagen (rabbit anti-human
collagen I, Chemicon/Merck Millipore, Burlington, USA), as
well as α-vascular smooth muscle cells (VSMC) (mouse anti-
human SMA, clone 1A4, DAKO, Santa Clara, USA) and
endothelium (rabbit anti-human von willebrand factor, DAKO,
Santa Clara, USA). In addition, immunhistochemical stainings
for glycophorin A (mouse anti-human CD235a, DAKO, Santa
Clara, USA), CD4 (mouse anti-human CD4, clone RPA-T4,
Invitrogen, Waltham, USA) and for FOXP3 (mouse anti-human
FOXP3, Abcam, Cambridge, UK) were performed. Samples were
classified by two independent investigators and are based on the
modified American Heart Association (AHA) Classification by
Virmani et al. (22).
Statistical Analysis
Continuous data were compared using Wilcoxon matched-pairs
signed rank test. Categorical variables are expressed as absolute
and relative counts and were compared using Chi-square test.
Plasma measurements were compared by Kruskal–Wallis test
for global assessment of differences in the data family before
limited group wise comparisons were done using Dunn’s test. To
account for multiple comparisons, statistical analyses of plasma
were adjusted according to Bonferroni (α <0.05/4). Histological
measurements were compared by Wilcoxon matched-pairs
signed rank test. Incidence of MINS was compared using Chi-
square test. Data are presented as median [interquartile ranges
(IQR)], unless otherwise stated, with whiskers extending from
5th to 95th percentile. Descriptive p-values are reported.
RESULTS
Baseline Characteristics
Clinical and demographical baseline characteristics for included
patients in relation to the time point of 1st and 2nd surgery
are presented in Table 1. Median age was 70 years and 75% of
patients were of male gender. The study population presented
with a high burden of cardiovascular disease. Consequently,
the great majority received cardiovascular medication. Overall
there were no changes in patients’ cardiovascular related health
between the two time points. CEA was the most common open
vascular procedure performed. Patients did not spend more
time in hospital or intensive care compared between the two
procedural time points (Table 1). The median time between the
two surgical procedures was 51 days (51 [47; 96] days).
Perioperative Systemic Inflammation
For assessment of the perioperative inflammatory response,
we measured plasma levels of IL-6, IL-10 and PTX3 prior
to and after 1st and 2nd surgery. Additionally, we pulled
patients CRP levels from routinely performed bloodwork
prior to and after 1st and 2nd surgery. Comparing pre- to
post-surgical measurements, plasma levels of IL-6 increased
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TABLE 1 | Baseline characteristics of patients.
Variable 1st surgery 2nd surgery p-value
Total (n = 40) Total (n = 40)
Age; years 71 (65; 75) 71 (66; 76)
Male sex; n (%) 30 (75) 30 (75)
Hospital days 7 (5, 9) 6 (5, 10) >0.05
ICU days 1 (0; 1) 1 (0; 1) >0.05
Type of surgical procedure, n (%)
Carotid 26 (65) 23 (58) >0.05
Peripheral artery 9 (23) 14 (35) >0.05
Aortic 5 (13) 3 (8) >0.05
Medical history, n (%)
Arterial hypertension 34 (85) 35 (88) >0.05
Diabetes mellitus 12 (30) 12 (30) >0.05
CAD or MI 16 (40) 17 (43) >0.05
Stroke or TIA 11 (28) 13 (33) >0.05
Heart failure 4 (10) 5 (13) >0.05
Preoperative medication, n (%)
ASS 29 (73) 31 (78) >0.05
ADP receptor antagonist 4 (10) 3 (8) >0.05
Beta blockers 24 (60) 23 (58) >0.05
Statins 28 (70) 29 (73) >0.05
AT II blockers 9 (23) 9 (23) >0.05
ACE inhibitors 27 (68) 21 (53) >0.05
Calcium antagonists 17 (43) 16 (40) >0.05
Diuretics 20 (50) 21 (53) >0.05
Data are presented as median (interquartile range) or as absolute number (percentage).
Continuous data were compared using Wilcoxon matched-pairs signed rank test.
Categorical variables were compared using Chi-square test. ICU, intensive care unit;
CAD, coronary artery disease; MI, myocardial infarction; TIA, transient ischemic attack;
AT angiotensin; ACE angiotensin converting enzyme.
after both surgeries [(1st procedure pre- 2.84 [1.16; 7.23]
pg/ml vs. post- 27.38 [14.82; 42.32] pg/ml, p < 0.0001) (2nd
procedure pre- 2.64 [1.51; 7.25] pg/ml vs. post- 19.62 [12.73;
53.74] pg/ml, p < 0.0001)] (Figure 2A). Also plasma levels
for IL-10 increased after both surgical procedures compared
to pre-surgery endpoints [(1st procedure pre- 0.73 [0.41;
0.98] pg/ml vs. post- 1.36 [0.81; 2.63] pg/ml, p = 0.0012)
(2nd procedure pre- 0.86 [0.60; 1.26] pg/ml vs. post- 1.34
[0.91; 2.87] pg/ml, p = 0.0126)] (Figure 2B). PTX3 increased
after both surgeries, comparing pre- to postoperative plasma
levels [(1st procedure pre- 0.55 [0.33; 0.99] ng/ml vs. post-
2.39 [1.24; 3.39] ng/ml, p < 0.0001) (2nd procedure pre-
0.57 [0.42; 1.19] ng/ml vs. post- 2.35 [1.48; 5.91] ng/ml, p
< 0.0001)] (Figure 2C). CRP increased after both surgical
procedures compared to preoperative values [(1st procedure
pre- 4 [1; 13] mg/dl vs. post- 27 [14; 60] mg/dl, p < 0.0001)
(2nd procedure pre- 1 [1; 9] mg/dl vs. post- 21.5 [13.5; 46]
mg/dl, p < 0.0001)] (Figure 2D). Pre-surgical values prior to
the 2nd procedure did not differ from measurements prior
to the 1st intervention. Neither were post-surgical values
after the 2nd procedure different from values after the 1st
intervention (Figures 2A–D).
Histological Assessment of Atherosclerotic
Lesions From Carotid Endarterectomy
Samples from CEA were stained for H&E (Figures 3A,B).
Size of necrotic core did not differ comparing CEA from 1st
to CEA from 2nd surgery (1st 27.16 [13.46; 48.85] % vs.
2nd 25.64 [7.05; 48.24] %, p > 0.05) (Figure 3C). Collagen
content was judged on staining of Collagen I (Figures 3D,
E), which did not differ comparing CEA from 1st to CEA
from 2nd surgery (1st 13.68 [10.33; 17.92] % vs. 2nd 11.30
[9.96; 19.83] %, p > 0.05) (Figure 3F). Samples were stained
for α-smooth muscle actin (αSMA) for detection of VSMC
(Figures 3G,H). Relative content of αSMA did not differ
between 1st and 2nd surgery (1st 4.62 [2.49; 6.97] % vs.
2nd 4.75 [3.75; 8.10] %, p > 0.05) (Figure 3I) Minimal
fibrous cap thickness also did not differ between samples
from 1st to 2nd surgery (1st 75.63 [52.72; 118.7] µm vs.
2nd 75.15 [58.15; 146.90] µm, p > 0.05) (Figure 3J). Samples
were then stratified into groups based on the modified AHA
Classification published by Virmani et al. (22). Overall, lesions
were of an intermediate to advanced stage. We chose the
classification by Virmani, as it focuses on AHA classification
IV to VI (22). Atherosclerotic lesions from the 1st CEA
more frequently showed plaque ruptures and less pathological
intimal thickening, classifying plaques overall as more advanced
(p < 0.001) (Figure 3K).
Quantification of Leukocyte
Subpopulations in Atherosclerotic Lesions
From Carotid Endarterectomy
Staining for CD68 resulted in no difference in relative content
between the two groups (1st 1.35 [0.60; 3.94] % vs. 2nd 1.15
[0.66; 3.76] %, p > 0.05) (Figures 4A–C). For quantification of
CD4 and FOXP3 positive cells, we adopted the quantification
method by Dietel et al. (15). Two regions with the size of
0.25 mm2 per section were identified in plaque shoulders
in synopsis with corresponding H&E stainings and then
analyzed for CD4 and FOXP3 positive cells, respectively
(Figures 4D–I). There was no difference in content of CD4
positive cells between 1st and 2nd surgery (1st 8.56 [6.32;
10.56] cells/0.25mm2 vs. 2nd 7.00 [4.84; 10.27] cells/0.25mm2,
p > 0.05) (Figure 4J). However, less FOXP3 positive cells were
detected in the samples from the 2nd surgery (1st 5.17 [3.25;
6.17] cells/0.25mm2 vs. 2nd 2.89 [2.21; 3.73] cells/0.25mm2,
p= 0.0174) (Figure 4K).
Incidence of Myocardial Injury After First
and Second Surgical Procedure
In patients suffering MINS median hs-cTnT value before surgery
was 29.83 ng l−1 [12.60; 55.70], min. 7.67, max. 74.16 ng
l−1 and 58.10 ng l−1 [27.46; 77.33], min. 13.19, max. 316.5
ng l−1 after the surgery. In the group without MINS median
hs-cTnT value before surgery was 12.40 ng l−1 [7.67; 27.60],
min. 3, max. 288 ng l−1 and 14.91 ng l−1 [8.54; 29.65], min.
3, max. 307.4 ng l−1 after the surgery. Incidence of MINS
in the whole cohort differed between 1st and 2nd surgical
intervention. After the 1st surgery one patient was diagnosed
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FIGURE 2 | Perioperative systemic inflammation. Measurements were performed in pre- and postoperative plasma samples of 1st and 2nd surgery. (A) IL-6
measured by CBA, (B) IL-10 measured by CBA, (C) PTX3 measured by ELISA, (D) CRP taken from routinely performed perioperative blood work. Graphs are
displayed as median with whiskers extending from 5th to 95th percentile. Data were compared using Kruskal–Wallis test for global assessment of differences in the
data family before limited group wise comparisons were done using Dunn’s test. To account for multiple comparisons, statistical analyses of plasma were adjusted
according to Bonferroni (α <0.05/4). Overall, both surgeries led to a similar inflammatory response associated with detection of markers for increased plaque
vulnerability. IL, Interleukin; PTX3, Pentraxin 3; CRP, C-reactive protein.
with MINS, after the 2nd surgery seven patients suffered MINS,
demonstrating an increased risk after the 2nd procedure (1 vs.
7 patients, 1st vs. 2nd surgery, OR 8.1, 95% CI [1.3; 93.2], p
= 0.0276) (Figure 5A). When taking into account only patients
with consecutive CEA, no patients suffered MINS after the
first procedure and three after the second (Figure 5B). In the
subgroup of patients with other surgeries, one patient was
diagnosed with MINS after the first procedure and four after the
second (Figure 5C).
DISCUSSION
In this post-hoc analysis we demonstrate that in our cohort
of patients at elevated cardiovascular risk undergoing vascular
surgery, reoperation was associated with an increased MINS
incidence. We analyzed atherosclerotic lesions from a subgroup
of patients who underwent CEA twice. In those patients we
found reduced Treg infiltration in 2nd surgery samples as a
sign of higher atherosclerotic plaque vulnerability. This finding
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FIGURE 3 | Histological assessment of atherosclerotic lesions from carotid endarterectomy. CEA samples of 17 patients who underwent bilateral CEA were selected
for histological assessment. (A,B) Representative H&E staining of CEA samples from the same patient of 1st and 2nd surgery. (C) Relative necrotic core size did not
differ between 1st and 2nd CEA sample. (D,E) Representative immune fluorescent staining of Collagen I of CEA samples from the same patient of 1st and 2nd
surgery (F) Relative Collagen I content did not differ. (G,H) Representative immune fluorescent staining of αSMA of CEA samples from the same patient of 1st and 2nd
surgery. (I,J) Relative content of αSMA and minimal thickness of fibrous cap did not differ. (K) Virmani Classification of samples harvested at both surgeries. Overall,
plaques were more advanced in the 1st surgical cohort. (C,F,I,J) Wilcoxon matched-pairs signed rank test. Data is presented as median with whiskers extending from
5th to 95th percentile. (K) Chi-square test. H&E, Hematoxylin & Eosin; L, Lumen, NC, Necrotic core; FC, Fibrous cap; αSMA, alpha-smooth muscle actin.
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FIGURE 4 | Assessment of plaque vulnerability based on leukocyte subpopulation content. (A,B) Representative immune fluorescent staining of CD68 of CEA
samples from the same patient of 1st and 2nd CEA. (C) Relative content of CD68 did not differ between 1st and 2nd CEA sample. (D) H&E staining of the sample
from the 1st CEA was used for identification of plaque shoulders. (E) Representative staining of CD4 and (F) of FOXP3 on a patient’s sample from the 1st CEA.
(Continued)
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FIGURE 4 | Arrows indicate CD4 and FOXP3 positive cells, respectively. (G) H&E staining of the same patient on the sample from the 2nd CEA. (H) Representative
staining of CD4 and (I) FOXP3 on the sample from the 2nd CEA. Arrows indicate positive cells. (J) Content of CD4 positive cells did not differ between 1st and 2nd
CEA sample in areas identified as plaque shoulders. (K) Samples from the 2nd surgery contained less FOXP3 positive cells in plaque shoulders. (C,J,K) Wilcoxon
matched-pairs signed rank test. Data is presented as median with whiskers extending from 5th to 95th percentile. L, Lumen; H&E, Hematoxylin & Eosin; NC, Necrotic
core; FC, Fibrous cap.
FIGURE 5 | Incidence of myocardial injury after first and second surgical procedure. (A) After the 1st surgery one patient was diagnosed with MINS, after the 2nd
surgery seven patients suffered MINS. The 2nd surgical procedure was associated with MINS (OR 8.1, 95% CI [1.3; 93.3]). (B) In the subgroup of patients undergoing
consecutive CEA, no patient suffered MINS after the first procedure and three after the second. (C) Display of patients with any other combination of surgery. One
patient was diagnosed with MINS after the first procedure and four after the second. Chi-square test. Data are presented as absolute numbers per group. CEA,
Carotid endarterectomy.
was independent from the incidence of MINS. There were no
differences in patients’ baseline characteristics. We did not detect
a difference in the pattern of measured plasma markers (IL-
6, IL-10, PTX3, CRP) between the first and second surgery.
Surgery was associated with an increase in IL-6 postoperatively.
High levels of postoperative IL-6 have proven to be an indicator
for adverse outcome after vascular and abdominal surgery (23)
and might hold a direct effect on plaque stability (10). This
is also in line with our finding that mice develop bigger
and more vulnerable plaques when exposed to perioperative
stress in an IL-6 dependent manner (8). Because perioperative
inflammation always consists of a balance between a pro-
and anti-inflammatory response, we measured IL-10 as an
immunosuppressant cytokine and also detected a postoperative
increase. Postoperative elevation of IL-10 has been well-described
(24). The surgical impact also was associated with an increase
in postoperative PTX3 and CRP after both surgeries. PTX3,
like CRP, belongs to the superfamily of pentraxins (25). In
contrast to CRP it is not of hepatic origin, rather than for
instance secreted by vascular endothelial cells and monocytes at
the site of inflammation, e.g., atherosclerotic lesions (25). As a
perioperative marker of inflammation, changes in PTX3 plasma
levels are subtle compared to CRP (25). We expected small
changes in the perioperative period. Recently several studies have
shown that elevated PTX3 plasma levels are an indicator for
atherosclerotic plaque vulnerability (26–28). Therefore, surgical-
associated inflammation, like the observed PTX3 increase in
plasma, could have an impact on local inflammatory processes
in atherosclerotic lesions.
Overall, we established that patients in our study exposed to
two surgical hits experienced increases in circulating pro- and
anti-inflammatory cytokines. Importantly, direct comparison
of the inflammatory response between both surgeries did not
differ, leaving the possibility of a stronger systemic inflammatory
response to the reoperation unlikely.
Histological assessment of atherosclerotic lesions from
patients, who underwent CEA twice, showed that necrotic
core size did not differ. Based on the fact that patients with
symptomatic carotid artery stenosis have larger necrotic core
sizes, we anticipated that there might be a difference in necrotic
core size (29). Also plaque progression, mainly through an
increase in necrotic core size, happens shortly before myocardial
infarction (30) and perioperative stress in mice is associated
with an increase in necrotic core size (8). Relative content of
collagen I did not differ between samples from 1st to 2nd surgery.
Collagen holds a particular role in plaque stability related to shear
stress (31) and adhesion of the lesion to the vessel wall (32).
Low minimum cap thickness is associated with plaque rupture
(33) but relative content of VSMC, as well as minimal thickness
of fibrous cap was not different between samples of 1st and
2nd surgery. When stratified according to the classification by
Virmani (22), CEA samples from the 1st surgery more frequently
showed plaque ruptures. This is in line with the expectation
that a vascular surgeon would choose the site with higher
stenosis, lesion complexity, and plaque vulnerability first for
surgical intervention.
Plaques from the 2nd surgery did not contain more
macrophages, quantified by CD68. Macrophages actively drive
development and progression of atherosclerotic lesions and
increase plaque vulnerability (34). IL-6 is a potential driver of
adhesion and transmigration of macrophages (35). As migration
processes of monocytes and macrophages in atherosclerosis have
been well-established (36), we hypothesized that perioperative
stress would lead to a higher influx of macrophages into the
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atherosclerotic lesions. This could not be confirmed. However,
findings are in line with results from both mouse models of
perioperative stress, which also did not show an increase in
macrophages within the atherosclerotic plaque (8, 9).
Low levels of CD4 cells in plaques are associated with
unstable atherosclerotic lesions (37). However, contrary to
our expectation, content of CD4 positive cells did not differ
between samples from 1st and 2nd surgery. CD4 positive cell
differentiate into various subtypes of helper T cells which have
been attributed pro- or anti-inflammatory in atherosclerosis
(38). Accordingly, we quantified Treg content. Patients’ CEA
samples harvested after the 2nd surgery contained less Tregs
compared directly to samples from the 1st surgery. Low numbers
of circulating Tregs are associated with atherosclerosis (39).
Additionally, we have recently shown that preoperative low
counts of Tregs are associated with cardiac adverse events after
non-cardiac surgery (17). When looking at the atherosclerotic
lesion itself, low numbers of Tregs within the plaque have been
associated with plaque vulnerability (15, 37). For the current
study peripheral blood Treg counts are not available. Therefore,
numbers cannot be compared to histological findings in this
cohort. However, our previous results (17) in connection with
the current findings lead to the intriguing hypothesis that
there is a connection between circulating Tregs, plaque stability
and patients’ outcome after surgery. Oxidative stress increases
Treg apoptosis in a high fat mouse model (40) rendering
this also a possible mechanism explaining the lower Treg
numbers in the plaques under perioperative stress from 2nd
surgery. As Tregs produce IL-10 (39) one could expect to see
differences in the IL-10 response to the 2nd surgical procedure.
However, Tregs are not necessarily the origin of postoperative
systemically secreted IL-10, as it has been recently shown that
a postoperative increase of IL-10 mRNA in patients’ blood was
not accompanied with FOXP3 mRNA increase but in fact a
decrease (24).
The 2nd surgical procedure was associated with MINS
(OR 8.1). This suggests that not only in mice (8) but
also in humans the perioperative inflammatory reaction
is associated with cardiovascular events and on top of
that might have an additive effect with repetitive surgical
procedures. At this point, we cannot provide sufficient
confirmative evidence to conclude that a lower in-plaque
content of Tregs leads to higher plaque vulnerability. However,
whilst acknowledging that MINS can be the consequence
of diverse events in the perioperative phase, our results will
stimulate further research and allow formulating the intriguing
hypothesis that perioperative reduction of Treg content in
atherosclerotic lesions might contribute to cardiovascular
complications (10).
Our study has several limitations. We would like to highlight
that only 70% of patients were on a perioperative statin treatment
after 1st surgery. After 2nd surgery, surprisingly this number only
increased to 73%, which does not represent current practice based
on AHA and ESC guidelines (4, 41). However, inclusion period
for this study was 2007 until 2010. The investigated population
in the post-hoc analysis is small, and results are therefore
rather exploratory than confirmatory of the hypothesis that
perioperative stress alters Treg content in atherosclerotic lesions
leading to higher plaque vulnerability and therefore MINS.
Plaque samples were not available for all patients. However, to
our knowledge we are the first to present a direct comparison of
atherosclerotic lesions before and after a surgical impact within
the same patient.
A prospective randomized trial to test if perioperative stress
alters plaque stability in humans with regard to histological
instability criteria is difficult to design. We performed a
sample size calculation (G∗Power 3) to estimate the number
of patients necessary for a prospective study. We calculated
with a more conservative odds ratio of 2, than 8.1, which we
found in this preliminary study. Based on this assumption,
240 patients are necessary to find the expected difference
in MINS vs. no MINS between 1st and 2nd surgery with
a power (1 − β) of 0.8 and α = 0.05 (Two dependent
groups Mc Nemar test). Keeping in mind that we identified
40 patients with two sequential vascular surgeries in a 5-
year inclusion period out of a total of 644 included patients,
highlights the difficulty of a prospective trial. Therefore, this
analysis of an observational study is a reasonable alternative.
Availability of atherosclerotic lesions from coronary vessels for
histological characterization is limited, making samples from
CEA a viable option. MINS is not exclusively a result of high
plaque vulnerability leading to plaque rupture but can also be
a result of an oxygen supply-demand mismatch (7, 42). We
therefore are not able to conclude from our findings that the
results are necessarily related. However, both findings show
independently that perioperative inflammation has a negative
impact on preexisting cardiovascular disease that worsens with
reoccurring exposure.
In conclusion, we are the first to show that sequential
surgeries are associated with MINS in patients undergoing
open vascular surgery. Both surgical procedures led to an
inflammatory response, whilst we could not detect any
differences for inflammatory plasma markers between the two
time points of surgery. Plaque samples from the 2nd procedure
contained less Tregs, which might be an indicator for higher
plaque vulnerability. Perioperative changes of Treg content in
atherosclerotic lesions are of interest to shine further light on
the impact of perioperative inflammation, especially in patients
at elevated cardiovascular risk.
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